RICHMOND, Va. , Oct. 28, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Stifel 2025 Healthcare Conference:
- Stifel 2025 Healthcare Conference – New York City, NY
Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Thursday, November 13 th . Joe Ciaffoni and Ryan Preblick will also participate in a fireside discussion on Thursday, November 13 th at 8:40 a.m. U.S. EST. Interested investors should contact their Stifel representative to schedule a meeting.
The fireside discussion will be publicly available and can be viewed using the following weblink: Stifel Fireside Chat Live Webcast .
About Indivior
Indivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.
View original content to download multimedia: https://www.prnewswire.com/news-releases/indivior-to-participate-in-the-stifel-2025-healthcare-conference-302596900.html
SOURCE Indivior PLC
/Quantum%20Computing/A%20concept%20image%20of%20a%20green%20and%20yellow%20motherboard_%20Image%20by%20Gorodenkoff%20via%20Shutterstock_.jpg)
/Super%20Micro%20Computer%20Inc%20logo%20on%20building-by%20Poetra_RH%20via%20Shutterstock.jpg)
/Advanced%20Micro%20Devices%20Inc_%20office%20sign-by%20Poetra_RH%20via%20Shutterstock.jpg)
/Close-up%20shot%20of%20Rivian%20R1T_%20Image%20by%20Trong%20Nguyen%20via%20%20Shutterstock_.jpg)